agenus inc (AGEN:NASDAQ CM)
Transactions by AGENUS INC (AGEN) in the last 6 months
Agenus Inc. (NasdaqCM:AGEN) acquired assets of Celexion, LLC from Flagship Ventures Fund 2007 LP fund of Flagship Ventures, Brian M. Baynes and Alexandria Equities, LLC for $10 million on April 7, 2015. Included in the asset acquisition is the SECANT(R) yeast display platform for the generation of novel monoclonal antibodies, key antibody assets, Celexion's novel approaches to generate antibodies against membrane bound protein targets such as GPCRs and ion channels. ...
Flagship Ventures Fund 2007, L.P.
Agenus Inc. (NasdaqCM:AGEN) announced that it has signed a stock purchase agreement for a private placement of 7,760,000 common shares at $4.51 per share with a new investor, Incyte Corporation for gross proceeds of $34,997,600 on January 9, 2015. As part of the transaction, the investor will acquire 11% stake in the company. The shares issued will be subject to a hold period of 12 months from the date of issue. The transaction is subject to customary closing conditions, ...
|No competitor information is available for AGEN.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|